153 results
Page 5 of 8
8-K
EX-10.1
7eh0kufzsd f7yl8
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
EX-3.1
0tnskzw
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
krkqfte70unxfy2ns
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
EX-2.1
2xyzr wznzitqfdtphif
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
424B5
k95l 6w5qs
31 Dec 19
Prospectus supplement for primary offering
4:28pm
8-K
EX-10.1
wf3n g6yzkau35tk1lx9
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-4.1
mg0nlw7mbag mah
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-10.1
sl01foxr0fmxmua
3 Dec 19
Departure of Directors or Certain Officers
6:55am
424B3
oysolzv jiz1ga84
18 Nov 19
Prospectus supplement
4:53pm
8-K
EX-10.1
8awzd1yf tl8zlww
30 Sep 19
EyeGate Enters Into Agreement for $1.9 Million Private Placement
6:55am